今年9月，FDA年夜头召开专家小组会议，并再次投票抉择特雷·西洛是否可以继续发卖。
In September, the drug agency reconvened the expert panel, and it again voted that Trasylol should continue to be sold.
埃里克·斯奈德，梅塔合作伙伴的一名分析家，声称大多数投资者期望食品药物管理局专家小组会议能对抗贫血药物的使用设置一个严密的限制。
Eric Snyder, an analyst at Mehta Partners, said most investors expected the FDA panel meeting to result in tighter restrictions on the use of anemia drugs.
应用推荐